Analyst Ratings For Acadia Healthcare (NASDAQ:ACHC)
Today, BMO Capital Markets raised its price target on Acadia Healthcare (NASDAQ:ACHC) to $45.00 per share.
Some recent analyst ratings include
- 2/22/2018-Credit Suisse Group Reiterated Rating of Neutral .
- 1/30/2018-Wells Fargo & Co initiated coverage with a Outperform rating.
- 10/30/2017-Mizuho Reiterated Rating of Buy .
- 10/26/2017-Craig Hallum Reiterated Rating of Buy.
- On 12/15/2017 Reeve B. Waud, Director, sold 100,000 with an average share price of $31.80 per share and the total transaction amounting to $3,180,000.00.
- On 8/22/2017 Brent Turner, President, sold 206,252 with an average share price of $50.69 per share and the total transaction amounting to $10,454,913.88.
- On 8/22/2017 Christopher L Howard, EVP, sold 53,713 with an average share price of $50.69 per share and the total transaction amounting to $2,722,711.97.
- On 8/22/2017 Joey A Jacobs, CEO, sold 500,000 with an average share price of $50.69 per share and the total transaction amounting to $25,345,000.00.
- On 8/22/2017 Reeve B. Waud, Director, sold 984,075 with an average share price of $50.69 per share and the total transaction amounting to $49,882,761.75.
- On 8/22/2017 Ronald Morgan Fincher, COO, sold 80,000 with an average share price of $50.69 per share and the total transaction amounting to $4,055,200.00.
- On 8/11/2017 William Grieco, Director, sold 2,000 with an average share price of $51.71 per share and the total transaction amounting to $103,420.00.
Recent Trading Activity for Acadia Healthcare (NASDAQ:ACHC)
Shares of Acadia Healthcare closed the previous trading session at with 39.43000030517578 shares trading hands.